|
Quality Id |
Measure Name |
High Priority |
Measure Type |
Measure Description |
|
047 |
Care
Plan |
Yes |
Process |
Percentage
of patients aged 65 years and older who have an advance care plan or
surrogate decision maker documented in the medical record that an advance
care plan was discussed but the patient did not wish or was not able to name
a surrogate decision maker or provide an advance care plan |
|
130 |
Documentation
of Current Medications in the Medical Record |
Yes |
Process |
Percentage
of visits for patients aged 18 years and older for which the eligible
professional or eligible clinician attests to documenting a list of current
medications using all immediate resources available on the date of the
encounter. This list must include ALL known prescriptions, over-the-counters,
herbals, and vitamin/mineral/dietary (nutritional) supplements AND must
contain the medications’ name, dosage, frequency and route of administration |
|
154 |
Falls:
Risk Assessment |
Yes |
Process |
Percentage
of patients aged 65 years and older with a history of falls that had a risk
assessment for falls completed within 12 months |
|
155 |
Falls:
Plan of Care |
Yes |
Process |
Percentage
of patients aged 65 years and older with a history of falls that had a plan
of care for falls documented within 12 months |
|
226 |
Preventive
Care and Screening: Tobacco Use: Screening and Cessation Intervention |
No |
Process |
Percentage
of patients aged 18 years and older who were screened for tobacco use one or
more times within 24 months AND who received tobacco cessation intervention
if identified as a tobacco user |
|
268 |
Epilepsy:
Counseling for Women of Childbearing Potential with Epilepsy |
No |
Process |
All
female patients of childbearing potential (12 - 44 years old) diagnosed with
epilepsy who were counseled or referred for counseling for how epilepsy and
its treatment may affect contraception OR pregnancy at least once a year |
|
282 |
Dementia:
Functional Status Assessment |
No |
Process |
Percentage
of patients with dementia for whom an assessment of functional status* was
performed at least once in the last 12 months |
|
283 |
Dementia
Associated Behavioral and Psychiatric Symptoms Screening and Management |
No |
Process |
Percentage
of patients with dementia for whom there was a documented symptoms screening*
for behavioral and psychiatric symptoms, including depression, AND for whom,
if symptoms screening was positive, there was also documentation of
recommendations for symptoms management in the last 12 months |
|
286 |
Dementia:
Safety Concerns Screening and Mitigation Recommendations or Referral for
Patients with Dementia |
Yes |
Process |
Percentage
of patients with dementia or their caregiver(s) for whom there was a
documented safety concerns screening * in two domains of risk: 1)
dangerousness to self or others and 2) environmental risks; and if safety
concerns screening was positive in the last 12 months, there was
documentation of mitigation recommendations, including but not limited to
referral to other resources or orders for home safety evaluation |
|
288 |
Dementia:
Caregiver Education and Support |
Yes |
Process |
Percentage
of patients with dementia whose caregiver(s)* were provided with education**
on dementia disease management and health behavior changes AND were referred
to additional resources*** for support in the last 12 months |
|
290 |
Parkinson’s
Disease: Psychiatric Symptoms Assessment for Patients with Parkinson’s
Disease |
No |
Process |
Percentage
of all patients with a diagnosis of Parkinson’s Disease [PD] who were
assessed* for psychiatric symptoms** in the past 12 months |
|
291 |
Parkinson’s
Disease: Cognitive Impairment or Dysfunction Assessment |
No |
Process |
Percentage
of all patients with a diagnosis of Parkinson’s Disease [PD] who were
assessed* for cognitive impairment or dysfunction in the past 12 months |
|
293 |
Parkinson’s
Disease: Rehabilitative Therapy Options |
Yes |
Process |
Percentage
of all patients with a diagnosis of Parkinson’s Disease (or caregiver(s), as
appropriate) who had rehabilitative therapy options (e.g., physical,
occupational, or speech therapy) discussed in the past 12 months |
|
317 |
Preventive
Care and Screening: Screening for High Blood Pressure and Follow-Up
Documented |
No |
Process |
Percentage
of patients aged 18 years and older seen during the submitting period who
were screened for high blood pressure AND a recommended follow-up plan is
documented based on the current blood pressure (BP) reading as indicated |
|
374 |
Closing
the Referral Loop: Receipt of Specialist Report |
Yes |
Process |
Percentage
of patients with referrals, regardless of age, for which the referring
provider receives a report from the provider to whom the patient was referred |
|
386 |
Amyotrophic
Lateral Sclerosis (ALS) Patient Care Preferences |
Yes |
Process |
Percentage
of patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) who were
offered assistance in planning for end of life issues (e.g. advance
directives, invasive ventilation, hospice) at least once annually |
|
402 |
Tobacco
Use and Help with Quitting Among Adolescents |
No |
Process |
The
percentage of adolescents 12 to 20 years of age with a primary care visit
during the measurement year for whom tobacco use status was documented and
received help with quitting if identified as a tobacco user |
|
408 |
Opioid Therapy Follow-up Evaluation |
No |
Process |
All
patients 18 and older prescribed opiates for longer than six weeks duration
who had a follow-up evaluation conducted at least every three months during Opioid Therapy documented in the medical record |
|
412 |
Documentation
of Signed Opioid Treatment Agreement |
No |
Process |
All
patients 18 and older prescribed opiates for longer than six weeks duration
who signed an opioid treatment agreement at least
once during Opioid Therapy documented in the
medical record |
|
414 |
Evaluation
or Interview for Risk of Opioid Misuse |
No |
Process |
All
patients 18 and older prescribed opiates for longer than six weeks duration
evaluated for risk of opioid misuse using a brief
validated instrument (e.g. Opioid Risk Tool,
SOAPP-R) or patient interview documented at least once during Opioid Therapy in the medical record |
|
419 |
Overuse
Of Neuroimaging For Patients With Primary Headache
And A Normal Neurological Examination |
No |
Efficiency |
Percentage
of patients with a diagnosis of primary headache disorder whom advanced brain
imaging was not ordered |
|
431 |
Preventive
Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling |
No |
Process |
Percentage
of patients aged 18 years and older who were screened for unhealthy alcohol
use using a systematic screening method at least once within the last 24
months AND who received brief counseling if identified as an unhealthy
alcohol user |
|
435 |
Quality
of Life Assessment For Patients With Primary Headache Disorders |
Yes |
Outcome |
Percentage
of patients with a diagnosis of primary headache disorder whose health
related quality of life (HRQoL) was assessed with a
tool(s) during at least two visits during the 12 month measurement period AND
whose health related quality of life score stayed the same or improved |